Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Vaccine

Astrazeneca Withdraws Vaxzevria Vaccine Due To Decline In Demand

AstraZeneca withdraws Vaxzevria vaccine due to decreased demand from newer, more effective mRNA vaccines. Strategic shift in global vaccination landscape.

Top News

Covishield manufacture stopped since December 2021; have disclosed all side effects in packaging: Serum Institute of India

Amidst huge uproar regarding the side effect of Covishield, the Serum Institute of India has said that it has stopped the manufacture and supply of additional doses of Covishield from December 2021 and this was done in view of the significantly decreasing demand for previous vaccines.

The Times of India

TOI Health News Morning Briefing | AstraZeneca withdraws COVID vaccine, West Nile fever outbreak, pregnancy guide for summer season, fitness tips and more

AstraZeneca withdraws COVID vaccine worldwide

The Times of India

From analysis to the latest developments in health,
read the most diverse news in one place.

AstraZeneca withdraws Covid vaccine worldwide due to 'surplus'

The pharma giant says the decision was made due to the availability of superior vaccines

Evening Standard

AstraZeneca Withdraws Covid Vaccine As Demand Dives

Anglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing Covid vaccine Vaxzevria, one of the first produced in the deadly pandemic, citing "commercial reasons" following a slump in demand.

International Business Times

AstraZeneca withdraws COVID-19 vaccine worldwide, cites commercial reasons

The pharmaceutical giant AstraZeneca's COVID-19 vaccine is being withdrawn worldwide after the company acknowledged for the first time in court documents that it can cause a rare and dangerous side effect, according to a report in the British Newspaper 'The Telegraph'. Read further on Dynamite News:

Dynamite News

AstraZeneca withdraws COVID vaccine worldwide weeks after admitting rare side effects

British pharmaceutical company AstraZeneca is currently withdrawing its COVID vaccine worldwide, months after it admitted for the first time in court documents that it can cause a rare and dangerous side effect, The Telegraph reported.

The Times of India

Read news from The Economist, FT, and more,
with one subscription

AstraZeneca withdraws Covid-19 vaccine worldwide, citing surplus of newer vaccines

Pharmaceutical company says newer shots led to decline in demand for AstraZeneca vaccine, which is no longer being manufactured or supplied

The Guardian - AU

TB vaccine MTBVAC gets CDSCO nod for phase II trials

CDSCO approves Bharat Biotech's phase II clinical trial for TB vaccine in India, focusing on safety and immunogenicity.

The Hindu

Scientists create vaccine with potential to protect against future coronaviruses

Researchers say experimental shot is step towards goal of creating vaccines before a pandemic has started

The Guardian - UK

The crucial role of accountability in healthcare: Lessons from the Covishield vaccine

In recent times, the field of healthcare has been under scrutiny like never before. The COVID-19 pandemic has not only brought medical challenges but has also highlighted the critical need for accountability in the healthcare field. AstraZeneca's statement regarding rare adverse effects related to blood clotting associated with its COVID-19…

The Times of India

Shot in the arm for winter disease fight

Graduate pharmacists have joined Victoria's vaccine workforce permanently ahead of the busy winter illness season, as the number of doses administered rises.

AAP

Health Department serves notice to private law college for spreading false rumours about Covishield vaccine

The Department of Health and Family Welfare has served a notice to Sri Siddaramaiah Law College, Chickballapur, for allegedly spreading false rumours that people who have been vaccinated with Covishield vaccine suffer from cardiac arrests. The department has told the college to issue a clarification.

The Hindu

No adverse effects reported from COVID vaccines in India: V. K. Saraswat

No adverse effects have been reported in India with regard to the vaccines used for battling COVID-19, senior scientist and NITI Aayog member V. K. Saraswat said here on Saturday.

The Hindu

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Covishield vaccine has had more benefits than risks, says study by Kozhikode doctors

Retrospective study from Kozhikode doctors finds minimal risks of Covishield vaccine, peer-reviewed for publication in medical journal.

The Hindu

The Science Quiz | Revisiting malaria and its unique challenges

The Hindu’s Science Quiz on revisiting malaria and its unique challenges.

AAP

Hopes that tick research will lead to vaccine

Researchers are collecting ticks from Australian farms in a bid to unlock information on the deadly parasites and develop a vaccine for animals and humans.

The Guardian - AU

Investors with questions: how a ‘clean food’ farm scheme born of Covid vaccine fears descended into rancour

Family Farms in NSW and Queensland promoted by Covid vaccine-sceptic group Parents With Questions were intended to operate outside a ‘corrupt’ food system. But not all has gone to plan

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

Launching an effective bird flu vaccine quickly could be tough, scientists warn

Federal health officials say the U.S. has the building blocks to make a vaccine to protect humans from bird flu, if needed. But experts warn we're nowhere near prepared for another pandemic.

Evening Standard

Families 'give up legal action' against Astrazeneca after Covid vaccine blood clot deaths

Twelve families have dropped their cases, according to reports

The Times of India

Covishield under scanner: Is Covaxin safe?

AstraZeneca's statement in court papers has sparked health concerns worldwide, especially in countries like India where COVISHIELD has been given to a large part of the population. The British pharmaceutical giant has admitted that its COVID vaccine can lead to a rare side effect called TTS or Thrombosis with Thrombocytopenia…

The Hindu

In India, all vaccine-related AEFI are routinely monitored and COVID is no exception, says health expert

All ‘Adverse Events Following Immunisation’ (AEFI) after COVID-19 vaccinations continue to be monitored, a senior official said.

Dynamite News

"Safety is primary focus for all our vaccines": Covaxin-developer Bharat Biotech amid reports on AstraZeneca vaccine

Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first." Read further on Dynamite News:

Latin Times

Pfizer Profits Drop On Lower Covid-19 Product Sales

Much lower sales of Covid-19 vaccine Comirnaty and therapeutic Paxlovid accounted for a 20 percent drop in first-quarter revenues to $14.9 billion compared with the year-ago period.

The Hindu

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’

Controversy over Covishield safety reaches Supreme Court, petition seeks expert panel to study risk factors and vaccine consequences.

1 … 99 100 101 102

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Melbourne

143 stories

Astra

92 stories

the Health Department

the Department of Health and Family Welfare

13 stories

the Serum Institute of India

12 stories

Covishield

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.